Chad Mineo: Platelet-Rich Plasma as an Adjunct to Rehabilitation in Grade 2 Hamstring Injuries
Chad Mineo, Physician Extender and Research Coordinator at Columbia University Irving Medical Center, shared a post on LinkedIn about a recent article by Clevio Desouza et al, adding:
“Platelet Rich Plasma (PRP) for Hamstrings:
High-quality ultrasound plus high-quality intervention equals better outcomes.
PRP hasn’t consistently beaten rehab for hamstring injuries—but context matters.
A 2025 RCT in European Journal of Orthopaedic Surgery and Traumatology showed:
US-guided PRP plus rehab equals faster RTP (approximately 26 versus approximately 34 days) plus improved early healing
Compare that to the negative British Journal of Sports Medicine (2015) trial:
- No imaging guidance
- Questionable PRP prep
- Broad patient selection
Not all PRP, or studies, are created equal.
Approach for grade 2 hamstrings:
- Rehab is the foundation (objective RTP criteria)
- PRP equals adjunct with uncertain upside
- Only if done right (image guidance, true PRP, structured rehab)
- Expect modest gains (days, not reinjury prevention)
Bottom line: PRP isn’t a magic bullet—but in the right hands, it may provide an edge.”
Title: Efficacy of platelet-rich plasma in grade 2 hamstring muscle injuries: results from a randomized controlled trial
Authors: Clevio Desouza, Vijay Shetty
Read the Full Article on Springer Nature.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 1, 2026, 14:53Hayley Emma Arron: Supporting Future Strategies for Venous Thrombosis in Spaceflight and Exploration
-
Apr 1, 2026, 14:41How Psychosocial Care Transforms Fear into Clarity and Stability – WFH
-
Apr 1, 2026, 14:23Ingo Ahrens: When Bleeding Poses a Greater Risk Than Ischemia
-
Apr 1, 2026, 13:48Anas Ibraheem: Apixaban Shows Superior Safety in Acute VTE While Matching Rivaroxaban Efficacy
-
Apr 1, 2026, 13:29Kevin Shortall: Life-Saving Blood Donation Amid Ireland’s Shortage
-
Apr 1, 2026, 13:12Kalyan Roy: Wrong Blood in Tube – A Small Error with Life-Threatening Consequences
-
Apr 1, 2026, 12:37Yves Bikorimana։ Normal MCV Doesn’t Always Mean Normal RBCs
-
Apr 1, 2026, 12:09Maxime Dely: Helping Patients Live More Freely with Sickle Cell Disease
-
Apr 1, 2026, 11:53Sharmila Manian: The Mystery of the Positive Direct Coombs Test in Donors